Skip to main content
. 2018 Mar 13;15(5):7335–7343. doi: 10.3892/ol.2018.8248

Figure 8.

Figure 8.

Comparison of overall survival rates between high and low SPARC expression levels in patients with stage III gastric cancer who had following adjuvant S-1 chemotherapy (P=0.000017, as determined using the log-rank test). SPARC, secreted protein, acidic and cysteine-rich.